Critical Care Medicine Department

Dr. Alnababteh obtained his MD from the University of Jordan where he was the recipient of the National Scholarship for Higher Education. He completed his internal medicine residency and served as Chief Resident at Georgetown University/Medstar Washington Hospital Center. His research focused on sepsis bundle outcomes and ECMO outcomes for COVID-19 patients. Dr. Alnababteh will join University of Pittsburgh for Pulmonary training.

Dr. Balasubramanian received her Doctor of Pharmacy degree from Ernest Mario School of Pharmacy at Rutgers University, and Doctor of Medicine degree from Robert Wood Johnson Medical School at Rutgers University. She completed residency training at University of Maryland Medical Center in internal medicine and continued on for a chief residency year. She is completing her pulmonary fellowship at the University of Maryland Medical Center. She was drawn to the NIH because of the program’s strong clinical training and supportive mentorship. Her current research involves evaluating the role of cell free DNA in patients with COVID-19 and advanced lung diseases.

Dr. Huapaya received his Doctor of Medicine degree from Universidad Peruana Cayetano Heredia in Peru. He completed residency training in Internal Medicine at Georgetown University Hospital and Fellowship in Pulmonary Medicine at the University of Maryland. He joined the NIH Critical Care Program because he sought a research-oriented program with an emphasis on clinical training. Dr. Huapaya is passionate about interstitial lung disease (ILD) and is working in Dr. Anthony Suffredini’s lab where they are studying the immune response of patients who have been infected with SARS-COV-2.

Dr. Lawandi graduated from the NIH Critical Care Medicine Fellowship in June 2022 and took a faculty position at McGill University. He received a Bachelor of Arts degree in Criminology from Carleton University, a Bachelor of Science degree in Cell and Molecular Biology and a Master’s of Science degree in Chemistry from Concordia University. He then obtained a Medical degree from McGill University, where he also completed residency training in Internal Medicine, as well as fellowship training in Infectious Diseases and Medical Microbiology. Dr. Lawandi chose to complete fellowship training in Critical Care Medicine at the National Institutes of Health Clinical Center for its high number of infectious diseases trained intensive care faculty, as well for the opportunity to conduct research in the field of antimicrobial resistance under the mentorship of Anthony Suffredini, Sameer Kadri, and John Dekker. HIs research interests include understanding the role of intracellular signaling in the coordination of resistance mechanisms of Pseudomonas aeruginosa to antibiotic exposure, as well as in the leveraging of electronic medical record databases to characterize trends in antimicrobial resistance epidemiology on a national scale.

Dr. Yek is a combined ID/ critical care fellow. Originally from Singapore, she attended medical school at the University of Cambridge and worked in the UK’s National Health Service before moving to the US. She completed internal medicine residency training followed by a year as chief resident at the University of Texas Southwestern. Her research under Dr. Jessica Manning (NIAID International Center in Cambodia) focuses on using metagenomic next-generation sequencing for a variety of applications including infectious disease diagnostics, genomic surveillance, and viral discovery. She also works with Dr. Sameer Kadri (Clinical Epidemiology Section, CCMD) using large cohort data to study COVID-19 and antimicrobial resistance in US hospitals.